Status:
COMPLETED
Evaluation of Anti-COVID 19 Pfizer Vaccination Effect on COVID 19 Detection Using Breath Analysis
Lead Sponsor:
Scentech Medical Technologies Ltd
Conditions:
Covid19
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objective of this study will be to evaluate the effect of vaccination on breath VOC content. By capturing and analyzing the breath of anti-COVID-19 vaccinated subjects during the period of antibo...
Detailed Description
The objective of this study will be to evaluate the effect of vaccination on breath VOC content. By capturing and analyzing the breath of anti-COVID-19 vaccinated subjects during the period of antibo...
Eligibility Criteria
Inclusion
- Age 18 to 75 years at the time of consent
- Capable of understanding written and/or spoken language
- Able to provide informed consent
- Assigned to undergo anti-COVID-19 vaccination
Exclusion
- Age under 18 years old
- Under guardianship or deprived of liberty
- Pregnant or lactating woman
- Not eligible for anti-COVID-19 vaccination
Key Trial Info
Start Date :
December 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 24 2021
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04842708
Start Date
December 24 2020
End Date
December 24 2021
Last Update
February 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shamir Medical Center
Be’er Ya‘aqov, Israel